Toolkit · Intellectual Property

The Trade Secret Litigation Toolkit

18 U.S.C. §§ 1836-1839

Type
Toolkit
Jurisdiction
National
Date
2026-03-06
Topic
Intellectual Property

This toolkit is a resource map for prosecuting and defending trade-secret misappropriation cases under the federal Defend Trade Secrets Act and the state Uniform Trade Secrets Act. It walks each litigation stage in sequence: identifying and particularizing the secret, proving reasonable secrecy measures, establishing misappropriation through acquisition, use, or disclosure, and navigating the inevitable-disclosure doctrine for departing employees. It maps the emergency-relief arsenal — temporary restraining orders, preliminary injunctions, and the DTSA's civil ex parte seizure — alongside the damages framework of actual loss, unjust enrichment, reasonable royalty, and exemplary damages. It covers criminal exposure under the Economic Espionage Act and the DTSA's whistleblower immunity, then turns to the defense playbook of independent development, reverse engineering, and overbreadth attacks. Throughout, it anchors doctrine to the governing statutes and leading cases and links to UpLaw's deeper protection guides, checklists, and toolkits.

The Trade Secret Litigation Toolkit

Intellectual Property > Trade Secret | Published 6 March 2026 - Updated 8 April 2026 | UpLaw - uplaw.us

A trade-secret case is won or lost long before trial — in how precisely you define the secret, how well you protected it, and how fast you move when it walks out the door. This toolkit maps every stage of the fight, on both sides of the "v."

Keywords: trade secret litigation, Defend Trade Secrets Act, DTSA, UTSA, misappropriation, inevitable disclosure, ex parte seizure, preliminary injunction, reasonable secrecy measures, Economic Espionage Act, whistleblower immunity, unjust enrichment, reverse engineering, reasonable royalty

How to read this toolkit

A trade-secret dispute is not one problem; it is a stack of them, and they must be solved in order. You cannot prove misappropriation until you have defined the secret. You cannot get an injunction until you have shown the secret was reasonably guarded. You cannot value the harm until you have decided which theory of misappropriation you are running. Skip a rung and the whole ladder collapses — usually at the preliminary-injunction hearing, when a judge asks the plaintiff's lawyer, "Tell me, specifically, what was taken," and the lawyer cannot answer.

This document is a resource map, not a form file. Each stage below gives you the plain-English doctrine, the anchor authority, the recurring traps, and a link into the deeper UpLaw guide, checklist, or toolkit where you go to actually do the work. Read it start to finish the first time to see the whole board. After that, jump to the stage you are living in.

Two statutes run underneath everything here. The Defend Trade Secrets Act (DTSA), 18 U.S.C. §§ 1836-1839, created a federal civil cause of action in 2016 for secrets "related to a product or service used in, or intended for use in, interstate or foreign commerce." The Uniform Trade Secrets Act (UTSA), adopted in some form by 48 states plus D.C., supplies the parallel state-law claim. The two are deliberately similar — the DTSA borrowed the UTSA's core definitions — so most of this toolkit applies to both. Where they diverge (ex parte seizure, the inevitable-disclosure treatment, whistleblower immunity), we flag it. For the doctrinal foundation beneath all of it, start with Trade Secret Law: How Secrecy Becomes Protectable Intellectual Property.

Our running example. Throughout, we follow Solstice Materials, Inc., a fictional advanced-battery company that spent four years and $30 million developing a proprietary electrolyte formulation and the process for coating it onto electrodes. Solstice's lead process engineer, Dr. Priya Vance, resigns and two weeks later surfaces as "VP of Cell Chemistry" at Meridian Cells, a well-funded rival. Within ninety days Meridian announces a battery with suspiciously familiar performance characteristics. Solstice's general counsel calls you. We will follow that case through every stage.

The trade-secret dispute at a glance

Before the stages, here is the whole lifecycle in one view:

  • Stage 1 — The threshold. Is there a trade secret at all, and can you describe it with particularity? Information that derives independent economic value from not being generally known, and is the subject of reasonable secrecy efforts.
  • Stage 2 — Reasonable secrecy measures. Did the owner actually protect it? This is where a protection program is your evidence — or the hole in your case.
  • Stage 3 — Misappropriation. Acquisition by improper means, or use/disclosure in breach of a duty. Usually proved by access plus similarity plus suspicious circumstances.
  • Stage 4 — Inevitable disclosure. The departing-employee wrinkle: can you enjoin someone from working for a competitor because they cannot help but use what they know?
  • Stage 5 — Emergency relief. TROs, preliminary injunctions, and the DTSA's civil ex parte seizure — the tools for the first 72 hours.
  • Stage 6 — Damages. Actual loss, unjust enrichment, reasonable royalty, and exemplary damages for willful misappropriation, plus attorney's fees.
  • Stage 7 — Criminal and immunity. Economic Espionage Act exposure, and the DTSA whistleblower immunity that can gut a claim if you ignored the notice requirement.
  • Stage 8 — The defense. Independent development, reverse engineering, no reasonable measures, and overbreadth — how the other side wins.

Stage 1 — The threshold: what is a trade secret and identifying it with particularity

The doctrine. Both statutes define a trade secret through three elements: (1) information — a formula, pattern, compilation, program, device, method, technique, or process — that (2) derives independent economic value from not being generally known to, and not readily ascertainable by, others who could profit from it, and that (3) is the subject of reasonable efforts to maintain its secrecy. See UTSA § 1(4); 18 U.S.C. § 1839(3). The subject matter is famously broad: source code, a customer list with buying patterns, a manufacturing tolerance, a negative know-how ("we tried this catalyst and it fails") all qualify. What does not qualify is anything generally known, readily reverse-engineered, or that the plaintiff cannot pin down.

Identification with particularity is the whole ballgame. The single most consequential — and most botched — task in trade-secret litigation is describing what was taken. Courts increasingly require the plaintiff to identify its trade secrets with "reasonable particularity" early, often before discovery opens; California codifies this in Code of Civil Procedure § 2019.210, and federal courts routinely order it. The reason is structural: an over-broad, shifting description ("our confidential business information and know-how") lets a plaintiff go fishing, moves the target every time the defendant proves independent development, and denies the defendant fair notice of what it must have avoided using. The trap on the other side is over-narrowing: describe the secret too tightly and the defendant walks through the gaps.

The craft. Aim for the level of a claim in a patent — specific enough to be a real, defined thing, general enough to capture the actual embodiment the defendant took. Distinguish the secret from the employee's general skill and knowledge, which the law does not protect. Separate each secret into a numbered list so the court can rule on them one at a time; a single strong secret beats a sprawling list of weak ones.

Solstice, applied. "Our battery technology" is not a trade secret; it is a marketing phrase. The disciplined identification reads: "(1) the electrolyte formulation specifying the additive package and concentration ranges in the Solstice Formulation Spec v7; (2) the electrode-coating process parameters — line speed, cure temperature, and solvent-recovery sequence — in Process SOP-114; and (3) the compiled test data mapping additive concentration to cycle life." Now every downstream stage has a target. Before you draft the complaint, you inventory: pull the results of any prior trade-secret audit so your identification tracks how the company itself catalogued the asset — an audit that predates the lawsuit is powerful proof the secret existed and was treated as one.

Stage 2 — Reasonable secrecy measures (and how protection programs make or break a case)

The doctrine. The statute does not require perfect secrecy, only reasonable efforts under the circumstances. A giant with a security budget is held to more than a garage startup, but everyone must do something: NDAs and confidentiality agreements, access controls and need-to-know limits, marking documents confidential, exit interviews, physical and network security, and vendor confidentiality terms. The absence of reasonable measures is not a technicality — it is a merits defense that defeats the claim outright, because information nobody bothered to protect is, by definition, not a secret.

Why the protection program is your evidence. In litigation, "reasonable measures" is proven with the artifacts a company built before the dispute. This is why the protection program and the lawsuit are the same project viewed at two moments in time. Every signed NDA, access log, and confidentiality legend becomes a trial exhibit. Build the program right and Stage 2 is a formality; build it loosely and the defendant's first summary-judgment motion targets exactly this element.

Where to build and audit it. For the full architecture, Building Trade Secret Protection from the Ground Up: A Comprehensive Guide is the deep dive, and the Trade Secret Protection Toolkit: Building and Defending a Confidentiality Program is its companion resource map. To stand a program up from scratch, work the Standing Up a Trade Secret Protection Program: A Practical Checklist; to prove you know what you hold, run the Auditing Your Trade Secrets: A Practical Checklist. The confidentiality agreements that anchor the program are drafted using the Building an Enforceable NDA Clause by Clause: A Practical Checklist and, for the deal context, Non-Disclosure Agreements for Technology Deals: Drafting for Enforceability.

The modern wrinkle: no perimeter. Reasonable measures used to mean a locked file room. Now the secret lives in cloud repositories and on laptops in employees' homes, and the security question is whether your access controls, device management, and monitoring travel with the data. Guarding Trade Secrets Without a Perimeter: Remote Work and the Cloud maps the controls courts now expect.

Solstice, applied. Solstice's counsel gathers Dr. Vance's signed confidentiality-and-invention-assignment agreement, the access logs showing SOP-114 was restricted to eleven named engineers, the "CONFIDENTIAL — SOLSTICE PROPRIETARY" legends on the formulation spec, and the record of the exit interview where Vance was reminded of her obligations and certified she had returned all materials. That last document does two things: it proves a reasonable measure, and it sets up the misappropriation case when forensics show she did not return everything.

Stage 3 — Proving misappropriation: acquisition, use, disclosure, and access + similarity

The three theories. "Misappropriation" is a defined term, and it covers two distinct wrongs. First, acquisition of a trade secret by a person who knows or should know it was obtained by improper means — theft, bribery, misrepresentation, breach or inducement of a duty, or espionage. Second, use or disclosure of a trade secret by someone who acquired it under a duty to keep it secret, or who knew it was derived from someone who breached such a duty. See UTSA § 1(1)-(2); 18 U.S.C. § 1839(5)-(6). A departing employee who emails herself the formulation spec has acquired by improper means; if she then feeds it into a competitor's process she has used it; if she shows it to the competitor's team she has disclosed it. One set of facts, three overlapping theories — plead them in the alternative.

"Improper means" versus fair competition. The line is doctrinal, not moral. Reverse engineering and independent development are expressly proper — the law protects secrecy, not a monopoly on the underlying information. Improper means covers conduct society condemns even when it is not independently illegal. The classic illustration is E.I. duPont deNemours & Co. v. Christopher, 431 F.2d 1012 (5th Cir. 1970): aerial photography of a plant under construction was "improper means" even though flying a plane broke no law, because it was a shortcut around commercial ethics designed to steal a secret before duPont could enclose it.

How it is actually proved: access plus similarity plus circumstances. Direct evidence of use is rare; almost nobody confesses. Trade-secret cases are built like circumstantial mosaics: (1) the defendant had access to the secret; (2) the defendant's product, process, or document is substantially similar in ways not explained by public information; and (3) the timeline and circumstances are suspicious — a sudden capability leap, a compressed development schedule that skips the years the plaintiff needed, mass downloads in the employee's final days, wiped devices, or a competitor's product that reproduces the plaintiff's mistakes and idiosyncratic choices. Forensic evidence — USB-insertion logs, cloud-sync records, email exfiltration, deleted-file recovery — is the spine of the modern case.

Preserve the evidence immediately. The moment you suspect misappropriation, litigation is reasonably anticipated and the duty to preserve attaches — to both sides. Get a litigation hold out before anything is overwritten; the departing-employee's laptop, the company's own logs, and the new employer's systems are all in play. Work the Issuing a Litigation Hold and Preserving ESI: A Practical Checklist on day one, and remember spoliation cuts both ways: a plaintiff who lets its own access logs roll off can lose the inference it needs. For where this sits in the broader case, the Federal Civil Litigation: A Roadmap and Resource Guide and the Civil Pretrial Toolkit: From Pleadings to Summary Judgment place the discovery machinery around your claim.

Solstice, applied. Forensics on Dr. Vance's returned laptop shows a mass copy of 340 files to a personal cloud folder eleven days before her resignation, including SOP-114 and the formulation spec, followed by a secure-wipe of her downloads folder on her last day. Meridian's announced cell reproduces Solstice's unusual solvent-recovery step — an engineering choice with no public antecedent. Access (she had it), similarity (the idiosyncratic step), and circumstances (mass copy plus wipe plus a ninety-day product) line up. That mosaic is the case.

Stage 4 — The inevitable-disclosure doctrine and departing employees

The doctrine. Sometimes a plaintiff cannot yet prove use, but the situation is combustible: a senior employee with deep knowledge of the crown-jewel secret has taken a nearly identical role at a direct competitor. The inevitable-disclosure doctrine lets a court enjoin the employment (or narrow its scope) on the theory that the employee cannot perform the new job without inevitably relying on — and thus disclosing or using — the former employer's secrets. The seminal case is PepsiCo, Inc. v. Redmond, 54 F.3d 1262 (7th Cir. 1995), where a general manager who knew PepsiCo's strategic beverage plans jumped to Quaker/Gatorade; the Seventh Circuit affirmed an injunction because he could not "compartmentalize" that knowledge.

The catch — it is jurisdictionally radioactive. Inevitable disclosure is a de facto non-compete imposed without a contract, so states split sharply. Many apply it in some form; California rejects it outright as an end-run around its statutory ban on non-competes (Bus. & Prof. Code § 16600). The DTSA itself pulls back: 18 U.S.C. § 1836(b)(3)(A) bars an injunction that would "prevent a person from entering into an employment relationship" and requires that conditions on employment be based on "evidence of threatened misappropriation and not merely on the information the person knows." Translation: under federal law you generally need more than knowledge alone.

Why this stage is really an employment-law stage. Whether you can restrain the employee at all often turns on non-compete and non-solicitation enforceability, which is a state-by-state (and increasingly federal-regulatory) minefield. Read this stage alongside The Future of Non-Competes: FTC Rulemaking and the State-Law Patchwork and, for the full separation-side playbook, The Employment Law Toolkit: From Hiring to Separation. The single most valuable prophylactic — done before anyone leaves — is a disciplined offboarding process; the Protecting Trade Secrets When Employees Leave: A Practical Checklist is the operational counterpart to this doctrine.

Solstice, applied. Solstice would love to enjoin Dr. Vance from working at Meridian entirely. Realistically, its odds depend on forum. If the case is in a jurisdiction that entertains inevitable disclosure, the near-identical role plus her knowledge of the exact formulation gets a hearing. But because Solstice also has hard forensic evidence of actual acquisition (the mass copy), it does not need to rely on inevitable disclosure at all — it has threatened and actual misappropriation, which satisfies even the DTSA's stricter standard. The lesson: inevitable disclosure is a fallback for when you lack the smoking gun, not a substitute for finding one.

Stage 5 — Emergency relief: TROs, preliminary injunctions, and the DTSA ex parte seizure

Why speed is everything. A trade secret, once disclosed, is gone forever — you cannot un-ring the bell. That makes the first days decisive and makes injunctive relief the primary remedy in most cases. The usual sequence is a temporary restraining order (TRO) to freeze the status quo, followed by a preliminary injunction (PI) hearing.

The four-factor test. To win a TRO or PI the movant must show (1) a likelihood of success on the merits — which loops back to Stages 1-3, meaning your secret must already be identified with particularity; (2) irreparable harm — usually straightforward, because loss of secrecy and loss of competitive position are hard to compensate in money; (3) the balance of equities tips in the movant's favor; and (4) the public interest. See Winter v. Natural Resources Defense Council, 555 U.S. 7 (2008). A trade-secret PI must be carefully scoped: it can bar use and disclosure, order return and forensic imaging, and enjoin further development derived from the secret, but it cannot be a naked employment ban (Stage 4).

The DTSA's unique weapon: civil ex parte seizure. Section 1836(b)(2) authorizes something no other IP statute does — a court order, obtained without notice to the defendant, directing U.S. Marshals to seize property to prevent propagation or dissemination of the trade secret. It is reserved for "extraordinary circumstances," and the bar is deliberately high: the applicant must show that a TRO would be inadequate because the target would evade, destroy, or move the material; that immediate and irreparable injury will occur; that the applicant's harm outweighs the target's; likelihood of success; specific identification of the matter to be seized and its location; and that the target would destroy or hide it if given notice. The court must set a post-seizure hearing within seven days, hold the seized material in the court's custody, and the applicant posts security. Wrongful or excessive seizure exposes the applicant to damages under § 1836(b)(2)(G). In practice, ex parte seizure is rare and courts prefer a narrowly tailored TRO with expedited forensic imaging — but the availability of seizure is a real bargaining chip.

Solstice, applied. Counsel files in federal court under the DTSA with a verified complaint and moves for a TRO ordering Dr. Vance and Meridian to (a) cease any use of the identified secrets, (b) return and not delete the copied files, and (c) preserve and image all devices and cloud accounts. Because Solstice can show the mass copy and the wipe, it argues seriously for ex parte seizure of the personal cloud folder — the classic "target will destroy the evidence" scenario. Even if the court prefers a TRO plus a forensic-imaging order to full Marshal-executed seizure, Solstice has locked down the evidence and frozen the use within seventy-two hours. For the incident-response mechanics that feed this filing — evidence preservation, forensic vendors, notification — see When a Breach Hits Your Crown Jewels: A Trade Secret Incident-Response Checklist and Protecting Trade Secrets During a Data Breach: Building IP Into Incident Response.

Stage 6 — Damages: actual loss, unjust enrichment, reasonable royalty, and exemplary damages

The menu. Both statutes let the plaintiff recover the fuller of two measures, so long as there is no double counting: (1) actual loss caused by the misappropriation — lost profits, lost sales, price erosion, or the diminished value of the secret; plus (2) unjust enrichment to the extent it is not already captured in actual loss — the defendant's gains attributable to using the secret, including a head-start or cost savings; or, in lieu of both, (3) a reasonable royalty — what a willing licensor and licensee would have negotiated for use of the secret. See UTSA § 3; 18 U.S.C. § 1836(b)(3)(B).

Head-start and avoided-cost theories. Trade-secret damages have a signature move: the "head-start" or "development-cost avoided" theory. Because the wrong is often shortcutting years of R&D, the defendant's benefit can be measured by the time and money it saved by not developing the secret itself — the value of arriving at market two years early. This is where Solstice's $30 million and four years become a damages anchor, not just a sympathy fact.

Exemplary damages and fees. For willful and malicious misappropriation, both statutes authorize exemplary (punitive) damages up to two times the compensatory award, plus attorney's fees. The DTSA conditions punitive damages and fees on compliance with the whistleblower-immunity notice requirement (Stage 7) — a compliance failure that can quietly strip your best remedies. Fees also run against a plaintiff who brings a claim in bad faith, which disciplines overreach.

Where the numbers get built. Damages in these cases are expert-driven and contested at Daubert. Reasonable-royalty and unjust-enrichment models overlap with patent-damages methodology, so the cross-disciplinary resources apply: What an IP Case Is Worth: A Guide to Intellectual Property Damages frames the IP-specific theories, and The Litigation Damages Toolkit: Valuing and Proving Money Awards covers the proof, causation, and expert-admissibility machinery that decides whether the number survives.

Solstice, applied. Solstice runs unjust enrichment on a head-start theory: Meridian's engineers testify (or the documents show) that replicating the formulation and coating process independently would have taken 30 months and roughly $22 million; that avoided cost, plus the profits on sales Meridian made during its stolen head start, is the enrichment. Solstice pleads willfulness from the mass copy and wipe to reach 2x exemplary damages and fees — and, critically, its confidentiality agreements included the DTSA whistleblower-immunity notice, so those enhanced remedies remain on the table.

Stage 7 — Criminal exposure (EEA) and whistleblower immunity

The criminal overlay. Trade-secret theft is also a federal crime under the Economic Espionage Act (EEA), 18 U.S.C. §§ 1831-1832. Section 1831 targets misappropriation intended to benefit a foreign government or instrumentality (economic espionage) and carries the heaviest penalties; § 1832 covers ordinary commercial theft of a trade secret related to interstate commerce, committed with intent to injure the owner and benefit someone else. The DTSA was grafted onto this criminal framework — which is why its definitions live in the same chapter. For a plaintiff, the EEA is leverage: a referral to the U.S. Attorney can run in parallel with the civil case, and criminal conduct strengthens the "improper means" and willfulness narratives. For a defendant, it raises the stakes enormously and implicates the Fifth Amendment across the civil and criminal tracks at once. For the broader picture of how civil and criminal IP exposure interlock, see The Real Cost of IP Piracy: Civil Damages, Criminal Charges, and Secondary Liability.

Whistleblower immunity — the notice trap. The DTSA created a critical carve-out that too many employers miss. Under 18 U.S.C. § 1833(b), an individual is immune from civil or criminal liability for disclosing a trade secret in confidence to a government official or an attorney solely to report or investigate a suspected violation of law, or in a sealed court filing. Here is the operational hook: an employer that wants to preserve exemplary damages and attorney's fees against an employee under the DTSA must provide notice of this immunity in "any contract or agreement with an employee that governs the use of a trade secret or other confidential information" — or cross-reference a policy document that sets it out. Omit the notice, and you keep the underlying claim but lose the enhanced remedies against that employee. This is a drafting fix, not a litigation fix — it must already be in your agreements before the dispute.

Solstice, applied. Solstice's confidentiality-and-invention-assignment agreement, updated when the DTSA passed, includes the § 1833(b) immunity notice, so its willfulness-based enhanced remedies survive. Separately, given the deliberate exfiltration and wipe, counsel evaluates an EEA referral under § 1832 — the mass copy of a commerce-related secret with intent to benefit Meridian fits the statute, and the referral pressure often accelerates a civil resolution.

Stage 8 — Defending a claim: independent development, reverse engineering, and overbreadth

Flip the case. A well-run defense attacks each stage the plaintiff had to climb, and it usually wins at the earliest weak rung.

Attack the identification (Stage 1). Move early to force the plaintiff to identify its secrets with reasonable particularity, and hold it to that description. A plaintiff that cannot describe the secret, or that keeps amending it to match whatever discovery reveals, is vulnerable to summary judgment. Argue that what the plaintiff calls a secret is the departing employee's general skill and knowledge, which the law does not lock up.

Attack reasonable measures (Stage 2). If the plaintiff did not use NDAs, did not restrict access, published the information, or let it circulate freely, there was no reasonable effort and therefore no trade secret. This is a merits defense, not a quibble.

Independent development and reverse engineering (Stage 3). These are the crown-jewel defenses, and they are lawful by definition. If the defendant developed the same process on its own, or derived it by lawfully acquiring and reverse-engineering a public product, there is no misappropriation — even if the result is identical. The defense lives or dies on contemporaneous documentation: lab notebooks, commit histories, design records, and a clean-room paper trail showing the independent path and the dates. The defendant that can show its own two-year development timeline defeats the "suspicious speed" inference.

Overbreadth and preemption. Attack an injunction that sweeps beyond the identified secret or that functions as an unlawful non-compete (Stage 4). Argue UTSA preemption: most enacting states displace overlapping common-law claims (conversion, unjust enrichment, unfair competition) that rest on the same misappropriation facts, so move to dismiss the duplicative tag-along counts. Raise the statute of limitations — typically three years from when misappropriation was or should have been discovered — and, where applicable, whistleblower immunity under § 1833(b).

Solstice, applied — from Meridian's chair. Meridian's best defense would be independent development, but the forensic mass copy and the reproduced idiosyncratic solvent step make that story hard to sell. Its realistic moves: (1) narrow Solstice's identification and argue the additive package is disclosed in published patents or is readily ascertainable; (2) argue the coating parameters are within Dr. Vance's general expertise, not a protectable secret; and (3) contest damages causation, arguing Meridian's sales came from its own capital and manufacturing, not the copied files. This is why the plaintiff's Stage 1 discipline matters so much — a sloppy identification hands the defense its opening.

The dispute as a working checklist

Use this as the one-glance gate. Do not advance a stage until the prior boxes are checked.

Threshold and secret

  • [ ] Each asserted trade secret identified with reasonable particularity, separated and numbered.
  • [ ] Independent economic value from secrecy articulated (and distinguished from public information and general skill).
  • [ ] Pre-litigation audit or inventory located and aligned with the identification.

Secrecy measures

  • [ ] NDAs / confidentiality agreements collected for the defendant and relevant custodians.
  • [ ] Access controls, confidential markings, and need-to-know limits documented.
  • [ ] Exit-interview record and return-of-materials certification pulled.

Misappropriation and preservation

  • [ ] Acquisition / use / disclosure theories pleaded in the alternative.
  • [ ] Access + similarity + suspicious-circumstances mosaic assembled.
  • [ ] Litigation hold issued to all custodians; forensic imaging of devices and cloud accounts arranged; own logs preserved.

Departing employee

  • [ ] Forum's treatment of inevitable disclosure and non-compete enforceability confirmed.
  • [ ] Threatened-misappropriation evidence identified (not merely "what the employee knows").

Emergency relief

  • [ ] TRO / PI four-factor showing built on the particularized identification.
  • [ ] Ex parte seizure evaluated against the § 1836(b)(2) extraordinary-circumstances criteria (and its risks).

Damages and enhancement

  • [ ] Actual loss, unjust enrichment (head-start / avoided cost), and reasonable-royalty models scoped with an expert.
  • [ ] Willfulness pleaded; DTSA § 1833(b) immunity notice confirmed present in the governing agreement (to preserve exemplary damages and fees).

Criminal / immunity / defense

  • [ ] EEA referral (§§ 1831-1832) evaluated.
  • [ ] Whistleblower-immunity exposure and UTSA preemption / limitations defenses assessed.

Primary authority

Secondary sources

  • Restatement (Third) of Unfair Competition §§ 39-45 (trade secrets and misappropriation).
  • Restatement (First) of Torts § 757 & cmt. b (the classic six-factor secrecy analysis).
  • Milgrim & Bensen, Milgrim on Trade Secrets (treatise).

Related UpLaw Resources

Related Guides & Articles

Related Checklists

Related Toolkits

This toolkit is general legal information from UpLaw (uplaw.us), not legal advice, and does not create an attorney-client relationship. Statutes, rules, and fees change; verify current requirements and consult qualified counsel before acting.